Published in Lab Business Week, March 12th, 2006
According to recent research from Iran, "Cardiomyocyte loss in the ischemically injured human heart often leads to irreversible defects in cardiac function.
"Recently, cellular cardiomyoplasty with mesenchymal stem cells, which are multipotent cells with the ability to differentiate into specialized cells under appropriate stimuli, has emerged as a new approach for repairing damaged myocardium."
"In the present study," wrote M. Kadivar and colleagues at the Pasteur Institute of Iran, "the potential of human umbilical cord-derived...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week